Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Medical Research Future Fund (MRFF) is a A$20 billion fund to support Australian health and medical research. It was set up in 2015 to deliver practical benefits from medical research and innovation to as many Australians as possible.

The Conversation logo

Unlike the other research funding agencies, such the National Health and Medical Research Council (NHMRC), most of the MRFF funding is priority-driven. It seeks to fund research in particular areas or topics rather than using open calls when researchers propose their own ideas for funding.

As the Nine newspapers outlined this week, researchers have criticised the previous Coalition government’s allocation of MRFF funds. There is widespread consensus the former health minister had too much influence in the allocation of funds, and there was limited and sometimes no competition when funding was directly allocated to one research group.

The current Health Minister, Mark Butler, has instituted a review. So how should the big decisions about how to spend the MRFF be made in the future to maximise its value and achieve its aims?

Read the full story on The Conversation website co-authored by , Professor of Health Economics, University of Oxford.

Oxford is a subscribing member of The Conversation. Find out how you can write for The Conversation.